Guidance: Antimicrobial resistance: develop solutions in the UK

Life Sciences Organisation Version 1 original current

Imported from official source

Overview of the UK's antimicrobial resistance (AMR) research infrastructure and advantages of investment in the UK's life science sector to support new treatments.

This version

Version
1 of 1
Recorded
September 20, 2026 19:53
Change
Initial
Content hash
c5d0d0490aeb9d178ef66bd5e5eec167
All versions
Revision history

Officially records where a publication came from, not whether it is true. Imported records are reproduced from an organization's own official source.